Evidence map›Paper›PMID 33866671›Full record

ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2021

Second field high-resolution HLA typing for immunologic risk stratification in kidney transplantation.

Aleksandar Senev, Marie-Paule Emonds, Maarten Naesens

Registry-linked trialOpen access · bronzeAbstract readLetterComment
PubMed Publisher
In one paragraph

Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06505200 (An Integrative Clinicopathological Decision Support System for Kidney Transplant Rejection), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06505200 active not recruitingnot on this map

An Integrative Clinicopathological Decision Support System for Kidney Transplant Rejection

TypeobservationalSponsorUniversitaire Ziekenhuizen KU LeuvenRan2004 to 2027Enrolled1,891ConditionsKidney Transplant Rejection, Kidney Transplantation, Kidney Transplant FailureArmsNo intervention
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Belatacept with time-limited tacrolimus coimmunosuppression modifies the 3-year risk of eplet mismatch in kidney transplantation.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2024
    Article
  5. The Clinical Significance of HLA Compatibility Scores in Lung Transplantation.Transplant international : official journal of the European Society for Organ Transplantation · 2024
    Observational
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Aleksandar SenevHistocompatibility and Immunogenetics Laboratory, Belgian Red Cross-Flanders, Mechelen, Belgium.ORCID https://orcid.org/0000-0002-6196-4669
Marie-Paule EmondsHistocompatibility and Immunogenetics Laboratory, Belgian Red Cross-Flanders, Mechelen, Belgium.ORCID https://orcid.org/0000-0002-2653-8656
Maarten NaesensKU Leuven Department of Microbiology, Immunology and Transplantation, Leuven, Belgium.ORCID https://orcid.org/0000-0002-5625-0792
KU Leuven · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Kidney TransplantationHistocompatibility TestingHLA AntigensRisk AssessmentHLA Antigensclinical research/practicegeneticskidney transplantation/nephrologyrisk assessment/risk stratificationsensitization

Identifiers

PMID33866671
OpenAlexW3156080710

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.